Decision Making in Small Animal Oncology 1st Edition David J. Argyle Download
Decision Making in Small Animal Oncology 1st Edition David J. Argyle Download
https://ebookultra.com/download/decision-making-in-small-animal-
oncology-1st-edition-david-j-argyle/
https://ebookultra.com/download/small-animal-oncology-1st-edition-
joanna-morris/
https://ebookultra.com/download/cancer-management-in-small-animal-
practice-1st-edition-carolyn-j-henry-dvm-ms-dacvim-oncology/
https://ebookultra.com/download/small-animal-oncology-an-
introduction-1st-edition-susan-m-north/
https://ebookultra.com/download/environmental-decision-making-in-
context-a-toolbox-1st-edition-chad-j-mcguire/
https://ebookultra.com/download/clinical-decision-making-in-mental-
health-practice-1st-edition-jeffrey-j-magnavita/
https://ebookultra.com/download/the-psychology-of-judicial-decision-
making-1st-edition-david-e-klein/
https://ebookultra.com/download/decision-making-in-medieval-
agriculture-1st-edition-stone/
https://ebookultra.com/download/collective-animal-behavior-david-j-t-
sumpter/
Decision Making in Small Animal Oncology 1st Edition
David J. Argyle Digital Instant Download
Author(s): David J. Argyle, Malcolm J. Brearley, Michelle M. Turek
ISBN(s): 9780813822754, 0813822750
Edition: 1
File Details: PDF, 5.55 MB
Year: 2008
Language: english
Decision Making in Small
Animal Oncology
Decision Making in Small
Animal Oncology
David J. Argyle
B.V.M.S., Ph.D., D.E.C.V.I.M.-C.A. (Oncology) M.R.C.V.S.
Malcolm J. Brearley
M.A., Vet.M.B., M.Sc. (Clinical Oncology), DipE.C.V.I.M.-C.A. (Oncology), F.R.C.V.S.
Michelle M. Turek
D.V.M., D.A.C.V.R. (Radiation Oncology), D.A.C.V.I.M. (Oncology)
Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been
merged with Wiley’s global Scientific, Technical, and Medical business to form Wiley-Blackwell.
Editorial Office
2121 State Avenue, Ames, Iowa 50014-8300, USA
For details of our global editorial offices, for customer services, and for information about how to apply for permission to
reuse the copyright material in this book, please see our website at www.wiley.com/wiley-blackwell.
Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted
by Blackwell Publishing, provided that the base fee is paid directly to the Copyright Clearance Center, 222 Rosewood
Drive, Danvers, MA 01923. For those organizations that have been granted a photocopy license by CCC, a separate
system of payments has been arranged. The fee codes for users of the Transactional Reporting Service are ISBN-13:
978-0-8138-2275-4/2008.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and
product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective
owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed
to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding
that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is
required, the services of a competent professional should be sought.
Disclaimer
The contents of this work are intended to further general scientific research, understanding, and discussion only and are
not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by
practitioners for any particular patient. The publisher and the author make no representations or warranties with respect
to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without
limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications,
changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment,
and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for
each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for
added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization
or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the
author or the publisher endorses the information the organization or Website may provide or recommendations it may
make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared
between when this work was written and when it is read. No warranty may be created or extended by any promotional
statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom.
Argyle, David J.
Decision making in small animal oncology / David J. Argyle, Malcolm J. Brearley, Michelle M. Turek.—1st ed.
p.; cm.
Includes bibliographical references and index.
ISBN 978-0-8138-2275-4 (alk. paper)
1. Dogs—Diseases—Diagnosis—Decision making. 2. Cats—Diseases—Diagnosis—Decision making. 3. Tumors in
animals. 4. Veterinary oncology. I. Brearley, Malcolm J. II. Turek, Michelle M. III. Title.
[DNLM: 1. Neoplasms—veterinary. 2. Algorithms. 3. Cat Diseases—diagnosis. 4. Cat Diseases—therapy.
5. Decision Support Techniques. 6. Dog Diseases—diagnosis. 7. Dog Diseases—therapy. SF 910.T8 A695d 2008]
SF992.C35A74 2008
636.089′6994—dc22
2008007429
A catalogue record for this book is available from the U.S. Library of Congress.
1 2008
To Sally, Blythe and Sam. For all your love and support, this is what I was doing
upstairs for all those weeks.
David J. Argyle
To Gregg, for his loving support of my endeavors. And to Mom, Dad and John
for their lasting wisdom and encouragement.
Michelle M. Turek
I should like to dedicate this book to my early mentors, Dave Bostock and the
late Larry Owen, who inspired me into clinical oncology. Also to my colleagues
over the years with whom I have continued to learn, and finally to the
oncologists of the future – if I have helped inspire them in any way then I
consider that a great honor.
Malcolm J. Brearley
Contents
Contributors ix
Foreword xi
2 Paraneoplastic Syndromes 19
Mala G. Renwick and David J. Argyle
19 Tumors of the Brain, Spinal Cord, Peripheral Nerves, and Special Senses 355
Malcolm J. Brearley and David J. Argyle
Index 373
Contributors
Alison Hayes BVMS CertVR MSC(Clin Onc) Dip Mala G. Renwick BSc. Bvet.Med MSc. (Clinical
ECVIM-CA(Oncology) MRCVS Oncology) MRCVS
RCVS Recognised Specialist in Veterinary Oncology Lecturer in Clinical Oncology
European Specialist in Veterinary Oncology Royal (Dick) School of Veterinary Studies
Senior Clinical Oncologist The University of Edinburgh
Animal Health Trust Hospital for Small Animals
Lanwades Park Easter Bush Veterinary Centre
Kentford, Suffolk Roslin, Midlothian
UK, CB8 7UU EH25 9RG
ix
x Contributors
Linda Roberts Dip AVN (Medical) RVN Michelle M. Turek, DVM, DACVIM (Oncology),
Royal Canin Cancer & Wellness Nurse DACVR (Radiation Oncology),
Royal (Dick) School of Veterinary Studies Staff oncologist
Hospital for Small Animals Angell Animal Medical Center’s Cancer Care Center,
Easter Bush Veterinary Centre Boston, MA
Roslin, Midlothian
EH25 9RG
Cancer is a major cause of morbidity and mortality in domestic animals. Recent reports suggest that there is
an increase in the prevalence of diagnosed cases of cancer in dogs and cats, partly because of the increased life
span through improved nutrition, vaccination, and control of infectious disease. As a consequence there is
increased demand on the practitioner to diagnose and manage cancer patients in general practice.
This book is not a comprehensive oncology text. It was specifically written to
• Provide veterinary students with the cancer knowledge they need in general practice.
• Provide general practitioners with a readable practice manual for rapid reference.
• Answer the common questions that specialist oncologists are asked by practitioners every day.
We have tried to arrange the material in the form of easy-to-follow algorithms that allow the clinician to
make appropriate decisions when faced with a cancer patient. We have also stressed the need for practitioners
to work with their pathologists and local specialist oncologists to provide the best care for their patients.
The reader must acknowledge that this is a rapidly changing field and best practice and knowledge may
change over time. Consequently, the authors recommend that readers should check the most up-to-date infor-
mation on procedures and drugs (including formulation, dose, and method of administration) prior to embark-
ing on therapy.
David J. Argyle
Malcolm J. Brearley
Michelle M. Turek
xi
Decision Making in Small
Animal Oncology
1
INTRODUCTION: CANCER BIOLOGY
AND TERMINOLOGY
David J. Argyle
A Definition of Tumor
• A tumor is any tissue mass or swelling and may or may not be neoplastic.
• Neoplasia is the abnormal growth of a tissue into a mass. It is usually phenotypically recognized by the
fact that its cells show abnormal growth patterns and are no longer under the control of normal
homeostatic growth-controlling mechanisms.
• Neoplasms can be considered as either benign or malignant tumors. Although the range of mechanisms
involved in the development of tumors and the spectrum of tissues from which tumors are derived is
diverse, they can be classified into three broad types:
1. Benign Tumors: Broadly speaking, these tumors arise in any of the tissues of the body and grow locally.
They can grow to a large size but are not invasive. Their clinical significance is their ability to cause local
pressure, cause obstruction, or form a space-occupying lesion such as a benign brain tumor. Benign tumors
do not metastasize.
2. In situ Tumors: These are often small tumors that arise in the epithelium. Histologically, the lesion appears
to contain cancer cells, but the tumor remains in the epithelial layer and does not invade the basement
membrane or the supporting mesenchyme. A typical example of this is preinvasive squamous cell carci-
noma affecting the nasal planum of cats.
3. Cancer: This refers to a malignant tumor, which has the capacity for both local invasion and distant spread
by the process of metastasis.
A Definition of Cancer
• Cancer is a disease of all vertebrate species and is well documented throughout history, with fossil records
indicating dinosaurs of the Jurassic period suffered from the disease.
• The Greek physician Galen is accredited with describing human tumors of having the shape of a crab,
with leglike tendrils invading deep into surrounding tissues—hence, the term cancer.
Key Point
We define cancer as any malignant growth or tumor caused by abnormal and uncontrolled cell divi-
sion, able to invade tissues locally and able to spread to other parts of the body through the lymphatic
system or the bloodstream. This is obviously a simplistic attempt at describing a complex disease that
can utilize a myriad of biological pathways to sustain growth and proliferation.
3
4 Decision Making in Small Animal Oncology
Nomenclature
The nomenclature of tumors is based upon two concepts:
• First, tumors can be considered as either benign or malignant. For simplicity, the pathobiological
differences between benign and malignant are outlined in Table 1.1.
• The second concept is concerned with the tissue or cell of origin (Tables 1.2, 1.3).
Cancer Biology
• Fundamental to our basic understanding of mammalian physiology is the concept of homeostasis.
• If we consider the body as a multicellular unit, cells within this unit form part of a specialized society that
cooperates to promote survival of the organism. In terms of homeostasis, cell division, proliferation, and
differentiation are strictly controlled and a balance exists between normal cell birth and the natural cell
death (Argyle and Khanna, 2006).
• Cancer can be considered as a breakdown in cellular homeostasis leading to uncontrolled cell division and
proliferation, which ultimately leads to a disease state.
• For many years, cancer researchers have considered a stochastic model of cancer development (McCance
and Roberts, 1997).
Table 1.1. The biological differences between benign and malignant tumors
Mesenchymal Named by the addition of the suffix oma to the cell type of origin:
• Fibrous tissue = fibroma
• Fat tissue = lipoma
• Cartilage = chondroma
Glandular epithelium Referred to as adenoma:
• A benign tumor of the sweat gland epithelium would be a sweat gland
adenoma.
Protective epithelium (squamous or Referred to as papilloma:
transitional) • Squamous papilloma of the skin (wart)
• Transitional papilloma of the urinary bladder
Nervous tissue Named by the addition of the suffix oma to the cell type of origin:
• A benign tumor of the astrocytes would be an astrocytoma.
Mesenchymal Named by the addition of the suffix sarcoma to the cell type of origin:
• Fibrous tissue = fibrosarcoma
• Fat tissue = liposarcoma
• Cartilage = chondrosarcoma
Glandular epithelium Referred to as adenocarcinoma:
• A malignant tumor of the sweat gland epithelium would be a sweat
gland or apocrine adenocarcinoma.
Protective epithelium (squamous or A malignant tumor of squamous epithelium would be a squamous cell
transitional) carcinoma.
A malignant tumor of transitional epithelium would be a transitional cell
carcinoma.
Round cell tumors Lymphoma and other lymphoid neoplasia
Plasmacytoma and multiple myeloma
Histiocytoma and other histiocytic diseases
Mast cell tumor
Transmissible venereal tumor
With the exception of the transmissible venereal tumor, round cell
tumors affect cell lines of hemolymphatic origin
• In this, cancer formation is the phenotypic end result of a whole series of changes that may have taken a
long period of time to develop.
• Following an initiation step produced by a cancer-forming agent on a cell, there follows a period of tumor
promotion (Figure 1.1). The initiating step is a rapid step and affects the genetic material of the cell. If the
cell does not repair this damage, promoting factors may progress the cell toward a malignant phenotype.
In contrast to initiation, progression may be a very slow process, and may not even manifest in the lifetime
of the animal.
• Over the past 4 decades, cancer research has generated a rich and complex body of information revealing
that cancer is a disease involving dynamic changes in the genome. Each stage of multistep carcinogenesis
reflects genetic changes in the cell with a selection advantage that drives the progression toward a highly
malignant cell. The age-dependent incidence of cancer suggests a requirement for between four and seven
rate-limiting, stochastic events to produce the malignant phenotype.
6 Decision Making in Small Animal Oncology
Initiation
Promotion
Promotion Promotion
Cancer Cell
Metastasis
Figure 1.1. The stochastic model of carcinogenesis: Cancer formation is the phenotypic end result of a whole
series of changes that may have taken a long period of time to develop. They can occur in any cell type in the body.
After an initiation step produced by a cancer-forming agent on a cell is a period of tumor promotion. Each stage of
multistep carcinogenesis reflects genetic changes in the cell with a selection advantage that drives the progression toward
a highly malignant cell. The age-dependent incidence of cancer suggests a requirement for between four and seven
rate-limiting, stochastic events to produce the malignant phenotype. Reprinted from “From Viruses to cancer stem cells:
Dissecting the pathways to malignancy” by Argyle D.J. and Blacking T.M. (The Veterinary Journal, 2007) with kind per-
mission from Elsevier.
Oncogenes
• Seminal to our understanding of cancer biology has been the discovery of the so-called “cancer genes,” or
oncogenes, and tumor suppressor genes.
• The term proto-oncogene is used to describe a gene that, in its native state, does not have transforming
potential to form tumors but that can be altered to promote malignancy. Once altered, the gene is referred
to as an oncogene.
• Most proto-oncogenes are key genes involved in the control of cell growth and proliferation and their
roles are complex.
• For simplicity, the mode of action of proto-oncogenes in the normal cell can be divided as follows (Table
1.4, Figure 1.2):
• Growth factors
• Growth factor receptors
• Protein kinases
• Signal Transducers
• Nuclear proteins
• Transcription factors
• The conversion of a proto-oncogene to an oncogene is a result of somatic events (mutations) in the genetic
material of the affected cell. The activated (mutated) allele of the oncogene dominates the wild-type
(nonmutated) allele and results in a dominant gain of function.
• The mechanisms of oncogene activation include the following (Figure 1.3):
• Chromosomal translocation: Where proto-oncogenes are translocated within the genome (i.e., from one
chromosome to another), their function can be altered. In human chronic myeloid leukemia (CML) a
chromosomal breakpoint produces a translocation of the c-abl oncogene on chromosome nine to a gene
on chromosome twenty-two (bcr). The bcr/abl hybrid gene produces a novel transcript whose protein
product has tyrosine kinase activity and can contribute to uncontrolled cellular proliferation. This tyrosine
Table 1.4. Oncogenes can be growth factors, growth factor receptors, protein
kinases, signal transducers, nuclear proteins, and transcription factors
Nuclear and
Transcription factors
Signal Transduction
Figure 1.2. Oncogenes are normal cellular genes involved in cell growth and proliferation: Most
proto-oncogenes are key genes involved in the control of cell growth and proliferation and include growth factors, growth
factor receptors, protein kinases, signal transducers, nuclear proteins, and transcription factors. The conversion of a
proto-oncogene to an oncogene is a result of somatic events in the genetic material of the target tissue. The activated
allele of the oncogene dominates the wild-type allele and results in a dominant gain of function. The mechanisms of
oncogene activation include chromosomal translocation, gene amplification, point mutations, and viral insertions. Reprinted
from “From Viruses to cancer stem cells: Dissecting the pathways to malignancy” by Argyle D.J. and Blacking T.M. (The
Veterinary Journal, 2007) with kind permission from Elsevier.
7
Other documents randomly have
different content
The Project Gutenberg eBook of The History
of Patient Grisel, 1619
This ebook is for the use of anyone anywhere in the United
States and most other parts of the world at no cost and with
almost no restrictions whatsoever. You may copy it, give it away
or re-use it under the terms of the Project Gutenberg License
included with this ebook or online at www.gutenberg.org. If you
are not located in the United States, you will have to check the
laws of the country where you are located before using this
eBook.
Language: English
G. L. Gomme, F.S.A.
and
H. B. Wheatley, F.S.A.
First Series.
IV.
THE HISTORY
OF
PATIENT GRISEL.
1619.
BY
LONDON:
PRINTED FOR THE VILLON SOCIETY.
1885.
Introduction.
1. See Originals and Analogues of Chaucer’s Canterbury Tales, part ii. pp.
150–176 (Chaucer Society).
There has been much controversy over these words. We must all
wish to believe that Chaucer met Petrarch at Padua and was friendly
with him; but although it is highly probable that he did so we have no
actual evidence other than this passage. Some say that Chaucer is not
speaking here in his own name but in that of a fictitious character,
and therefore the statement goes for nothing. Another objection is
that here Chaucer’s indebtedness to Boccaccio is overlooked and all
the credit is given to Petrarch. It is highly probable however that
Chaucer was interested in the story from Petrarch’s talk, and that
when he decided to make it one of his Canterbury Tales he adapted it
from Petrarch’s translation of Boccaccio, which is referred to farther
on in the Prologue:—
“I say that he first with heigh stole enditeth
(Er he the body of his tale writith)
A proheme, in the which descrivith he
Piemounde, and of Saluces the contre,
And spekith of Appenyne the hulles hye,
That ben the boundes of al west Lombardye.”
That this is the true origin of the Clerk’s tale is confirmed by the
fact that Petrarch varied somewhat from Boccaccio’s original, and in
these variations Chaucer follows Petrarch. An impossible tale such as
this requires all the art of the true poet to make it delightful to us,
and this of course we have in Chaucer. It is far different when we
come to read the common-place prose of the chap-book or the
equally common-place verse of the ballad-monger.
The picture of patience carried to the extreme in the wife and of
brutal violence in the husband is so out of harmony with our present
views that it is somewhat difficult to read the story with patience. We
are wrong, however, in taking it in this spirit, and Professor Hales
has so beautifully expressed the true motive of this mediæval picture
that I feel I cannot do better than transfer to these pages his remarks
in the publication of the Chaucer Society containing Originals and
Analogues of some of Chaucer’s Canterbury Tales:[2]—“Now, it is the
characteristic of the unsophisticated mediæval litterateur that he
deals with one idea at a time. It would often lead to a highly injurious
conclusion to attach at all equal a moral importance or rather any
moral importance to the subordinate parts of what he sets forth. The
central lesson is kept well in view; the others must look to
themselves. The principal figure is brought into relief with
enthusiasm; on the mere surroundings and background little or no
care is spent.... And so in the story of Griselda: if we would read it in
the spirit of the day when it became current we should not vex
ourselves into any righteous indignation against the immediate
author of her most touching distresses. The old story does not make
the marquis a monster in human shape; indeed, it represents him as
a man of a noble and lovable nature; if he is not so, then even in the
end Griselda reaps no earthly reward in permanently securing his
admiration and love. And yet this marquis perpetrates inexpressible
cruelties; he is a very wolf, ruthlessly teasing and tearing the gentlest
of lambs. The explanation is in accordance with what has just been
said: the patience of Griselda is the one theme of the tale, and
nothing else is to be regarded. In relation to her the marquis has no
moral being; he is a mere means of showing forth her supreme
excellence; a mere mechanical expedient. He is no more morally than
a thorn in the saint’s footpath, or a wheel, or a cross. Surely it is vain
to be wroth with him. Who rages against the mere fire that enfolds
the martyr, or the nails that pierce the hands of a crucified Believer?
Indeed, nothing in the tale is of any ethical moment but the carriage
of the heroine herself. The eyes and the heart of the old century when
she first appeared were fastened devoutly on that single form, and let
all else go by. She is wifely obedience itself, nothing else. Before that
virtue all other virtues bow. It enjoys a complete monopoly, an
absolute sway. Other moral life is suspended in this representation of
it. She has but one function; for her there is but one sin possible, and
that is to murmur. She is all meekness, all yielding, all resignation.
2. Part ii. 1875, p. 174.
“Such a figure has comparatively few charms for us of these latter
days. But it pleased the world once—even down to Shakespeare’s
time, who himself portrayed it in one of his earliest plays: Catherine
in the Taming of the Shrew is a phase of Griselda. Perhaps in ages
when much most ignorant abuse of women prevailed in literature—
abuse springing mainly out of the vile prejudices and superstitions of
the mediæval Church—some such figure might have been expected to
arise. It is the figure of a reaction. The hearts of men refused to
accept the dishonouring pictures so often drawn of their fellow
mortals. They rose in a loyal insurrection against lying fables of
essential wantonness and of shameful obstinacy. To such chivalrous
rebels the pale, sad, constant face of Griselda showed itself as the
image of far other experiences and histories; and they gazed on it as
on the face of their saint. With an infinite reverence they saw her still
calm and quiet in the midst of anguishes, with heart breaking but lips
uttering no ill word, with eyes that through the tears with which
kindly nature of herself would relieve the terrible drought of sorrow
still looked nothing but inalienable tenderness and love.”
The French have claimed for their country the origination of the
story of Griselda; but their claim cannot be allowed. The Abbé de
Sade in his Life of Petrarch asserts that the story is to be found in a
manuscript called Le Parement des Dames; but it appears that this
manuscript was the work of Olivier de la Marche, who was not born
until long after the death of Boccaccio. Boccaccio’s novel was
translated into French and published at Paris about the year 1510 as
La Patience de Grisilidis; it was published also at Troyes about 1562.
Apparently, however, the French were the first to bring Griselda
upon the stage; for, according to Warton, the Comedians of Paris
represented a mystery in French verse entitled Le Mystere de
Griseildis, Marquis de Saluces, mis en rime françoise et par
personnaiges in 1393. This was not printed until about 1550, when
Jehan Bonfons published it at Paris. His edition was reprinted in
1832.
Ralph Radcliffe, a somewhat voluminous play-writer, who
flourished towards the close of the reign of Henry VIII., is said by
John Bale to have written an English comedy entitled “Patient
Griselde,” and Hans Sachs in Germany converted the story into a
drama as early as 1550; but in Italy, the land of its birth, it was not
dramatised until 1620.
It was not possible for a story which had early taken such a strong
hold upon the popular imagination to remain long without becoming
the property of the ballad-writer, but we cannot tell if he forestalled
the writer of popular histories. In the Stationers’ Registers we find
three entries of Griselda as early as the year 1565–6; the following
two relate to the ballad:—
Rd. of Owyn Rogers, for his lycense for pryntinge of a ballett intituled the
sounge of pacyente Gressell unto hyr make [mate]
iiij d.
Rd. of Wylliam greffeth, for his lycense for pryntinge of ij ballettes to the
tune of pacyente gressell
iiij d.
There is a copy of the ballad (in one, not two parts) in the Percy Folio
Manuscript. See Hales and Furnivall’s edition, 1868, vol. iii. p. 421.
1565–6. Rd. of Thomas Colwell, for his lycense for prynting of an history of
meke and pacyent Gresell
iiij d.
1568–9. Rd. of Thomas Colwell, for his lycense for pryntinge of the hystory
of pacyent gresell, &c.
viij d.
The Robert Shaa or Shaw here mentioned was, Mr. Collier tells us,
one of the temporary managers of the company of the Earl of
Nottingham’s players. The comedy was entered at Stationers’ Hall for
publication on the 28th March, 1600, as “the Plaie of Patient
Grissell,” but it did not appear until three years afterwards.
The Pleasant Comodie of Patient Grissill. As it hath beene sundrie
times lately plaid by the right honorable the Earle of Nottingham
(Lord high Admirall) his servants. London. Imprinted for Henry
Rocket, and are to be solde at the long shop under S. Mildred’s
Church in the Poultry. 1603. 4to. 42 leaves.
The play is anonymous, but the entry in Henslowe’s Diary informs
us who the authors were.
Patient Grissil: a Comedy by Thomas Dekker, Henry Chettle, and
William Haughton. Reprinted from the Black-Letter edition of 1603,
with an Introduction and Notes [by J. Payne Collier]. London.
Printed for the Shakespeare Society. 1841. The introduction contains
an interesting account of the history of Griselda.
On August 30th, 1667, Pepys saw at Bartholomew Fair the puppet
play of “Patient Grizill,” and Warton in a note to his History of
English Poetry writes: “I need not mention that it is to this day
represented in England on a stage of the lowest species and of the
highest antiquity: I mean a puppet show.”
“The Patient Countess,” in Percy’s Reliques from Warner’s Albions
England, is a totally different story from that of the patient wife of
the Marquis Walter.
Warton mentions a MS. poem by William Forrest, and, as it has
lately been printed, I give the title here, although it contains no
notice of the original Grisild.
The History of Grisild the Second: a Narrative in Verse of the
Divorce of Queen Katharine of Arragon. Written by William Forrest,
sometime Chaplain to Queen Mary I., and now edited for the first
time from the Author’s MS. in the Bodleian Library by the Rev. W. D.
Macray, M.A., F.S.A. London. Printed by Whittingham and Wilkins
at the Chiswick Press, 1875. 4to. Roxburghe Club.
The Griselda literature is a tolerably large one, and it is therefore
scarcely necessary in this place to give more than the above general
indication of an interesting subject. It may be noted that the titles of
the works on the subject in the library of the British Museum occupy
nine pages of the manuscript catalogue.
The patience of Griselda is almost as much a common-place of
literature as that of Job, and writers are full of references to her cruel
fate. In a Balade translated by Lydgate from the Latin “Grisilde’s
humble patience” is recorded.
In Thomas Feylde’s “Contraversye bytwene a Lover and a Jaye,”
printed without date by Wynkyn de Worde, we read:—
“Ryght fewe of Grysyldes kynde
Is now left on lyve.”
At London:
1619.
The Historie of Patient Grisel, made Marchionesse
of Saluss, in which is Exemplified the true
Obedience and Noble Behaviour of Vertuous
Women towards their Husbands.
Chap. I.
How the Marquesse of Saluss passed the time of his youth
without any desire of mariage, till he was requested by the
faire entreatie of a favorite, and other gentlemen, to affect
a wife, both for the good of the country and the honour of
himselfe; with his answer to the same.
After the ladies had thus adorned poore Grisel with robes befitting
her estate, the Marquesse and all the noble company returned to
Saluss, and in the Cathedrall Church, in sight of the people,
according to the fulnesse of religious ceremonies, they were espoused
together, and with great solemnitie returned to the palace. Herein yet
consisted the admiration, that no word of reproach was murmured,
nor eie looked unpleasantly upon her; for by her wonderfull
demeanour shee had gained so much of opinion that the basenes of
her birth was not thought upon, and all her graces concurring made
them verely beleeve shee was extracted of princely lineage: no man
once supposed that shee could be Grisel, daughter to poore Janicola,
but rather some creature metamorphosed by the powers of heaven:
for besides the outward statelinesse and majestical carriage of
herselfe, the wonderfull modestie and exact symmetry of her
countenance, the admirable beauty and extraordinary favor of her
visage, her faire demeanour had a kinde of attraction, and her
gratious words a sweet delivery; so that all that came to her were glad
of their accesse, and they which went from her triumphed for their
good speed: yea, report extended so far, that she was not onely
visited by her owne lords and ladies with reverence, but attended on
with strangers, who came from all quarters to see her and to bee
behoulding to their owne judgements; so that if the Marquesse loved
her before for her own worth, he now reverenced her for others
respect; the rather, because he found a blessing attending her
presence, and all people pleased in the contract? For when any
controversie hapned betweene himselfe and his nobles, she was so
nobly minded, that what she could not obtaine by fair intreaty she
yet mitigated by sweet perswasion. When any unkindnes hapned of
forraine prince, shee urged those blessings of peace, and reasoned
Welcome to our website – the ideal destination for book lovers and
knowledge seekers. With a mission to inspire endlessly, we offer a
vast collection of books, ranging from classic literary works to
specialized publications, self-development books, and children's
literature. Each book is a new journey of discovery, expanding
knowledge and enriching the soul of the reade
Our website is not just a platform for buying books, but a bridge
connecting readers to the timeless values of culture and wisdom. With
an elegant, user-friendly interface and an intelligent search system,
we are committed to providing a quick and convenient shopping
experience. Additionally, our special promotions and home delivery
services ensure that you save time and fully enjoy the joy of reading.
ebookultra.com